会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 62. 发明授权
    • Methods of treatment using methotrexate compositions
    • 使用甲氨蝶呤组合物治疗方法
    • US5292731A
    • 1994-03-08
    • US916432
    • 1992-07-21
    • Bernard Loev
    • Bernard Loev
    • A61K31/555
    • A61K31/555
    • Compositions containing metal salts of methotrexate and methotrexate derivatives or analogs are disclosed. Such compositions comprise a metal salt, preferably a zinc salt, of methotrexate or a methotrexate derivative or analog and a carrier suitable for delivering the metal salt in the desired pharmacological form. Methods of treatment are also disclosed in which such compositions are topically applied or orally or parenterally administered to a patient. The metal salt is present in the treating composition in an amount sufficient to produce the desired therapeutic effect upon application or administration.
    • 公开了含有甲氨蝶呤和甲氨蝶呤衍生物或类似物的金属盐的组合物。 这样的组合物包含甲氨蝶呤或甲氨蝶呤衍生物或类似物的金属盐,优选锌盐,和适于递送所需药理学形式的金属盐的载体。 还公开了治疗方法,其中这些组合物被局部施用或口服或肠胃外给药给患者。 金属盐以足以在施用或施用时产生所需治疗效果的量存在于处理组合物中。
    • 64. 发明授权
    • Antihypertensive lactams
    • 抗高血压内酰胺
    • US4347246A
    • 1982-08-31
    • US263824
    • 1980-05-15
    • John T. SuhBruce E. WilliamsJerry W. SkilesBernard Loev
    • John T. SuhBruce E. WilliamsJerry W. SkilesBernard Loev
    • C07D277/06C07D279/12C07D281/06C07D513/04A61K31/55C07D281/04C07D281/18
    • C07D513/04C07D277/06C07D279/12C07D281/06
    • A compound of the formula ##STR1## wherein: R.sub.1 is independently lower alkyl having from 1 to 6 carbon atoms, lower alkenyl having from 2 to 6 carbon atoms, lower alkynyl having from 2 to 6 carbon atoms, hydroxy, hydroxyalkyl, alkoxy, thio, thioalkyl, alkylmercapto, amino, aminoalkyl, alkylamino, nitro, cyano, alkanoyl, carboxy, carboxyalkyl, carbalkoxy, carbalkoxyalkyl, halogen, alkylsulfoxy, alkylsulfonyl, sulfonyl, sulfonamido, trifluoromethyl, or methylenedioxy, wherein the alkyl group in hydroxyalkyl, thioalkyl, aminoalkyl, carboxyalkyl, alkoxy, alkylmercapto, alkylsulfoxy, alkanoyl, carbalkoxy, and carbalkoxyalkyl has from 1 to 6 carbon atoms,n is an integer from 1 to 4 inclusive,R.sub.2 is selected from the group consisting of hydrogen and cycloalkyl, wherein the cycloalkyl group contains from 3 to 16 carbon atoms,R.sub.3 and R.sub.4 are hydrogen, andY is oxygen, sulphur, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.The compounds are useful as antihypertensives, and have angiotensin converting enzyme inhibitory activity.
    • 下式化合物其中:R 1独立地为具有1至6个碳原子的低级烷基,具有2至6个碳原子的低级烯基,具有2至6个碳原子的低级炔基,羟基,羟基烷基,烷氧基,硫代 ,烷基巯基,氨基,氨基烷基,烷基氨基,硝基,氰基,烷酰基,羧基,羧基烷基,烷氧基,烷氧基烷基,卤素,烷基磺酰氧基,烷基磺酰基,磺酰基,亚磺酰氨基,三氟甲基或亚甲二氧基,其中羟基烷基, ,羧基烷基,烷氧基,烷基巯基,烷基亚磺酰基,烷酰基,烷氧基和烷氧基烷基具有1至6个碳原子,n是1至4的整数,其中R 2选自氢和环烷基,其中环烷基包含 3至16个碳原子,R3和R4是氢,Y是氧,硫,= NR1,= NOR1或= N-NH2,R1与上述定义相同。 该化合物可用作抗高血压药,并具有血管紧张素转换酶抑制活性。